Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Heilongjiang Tianyang Pharmaceutical is a comprehensive pharmaceutical enterprise based in Harbin, China, specializing in the research, development, and large-scale production of Traditional Chinese Medicine (TCM) and chemical pharmaceuticals. The company maintains a diverse product portfolio that includes small-volume injections, tablets, capsules, and granules, with a core therapeutic focus on cardiovascular and cerebrovascular health. Key commercial products include Shuxuening Injection and Dengzhan Xinyitong Injection, which are widely used in China for treating ischemic conditions and improving microcirculation. Tianyang Pharmaceutical operates modern, GMP-certified manufacturing facilities to ensure high standards of quality control across its generic and proprietary lines. The firm plays a significant role in the regional healthcare economy by integrating traditional herbal pharmacology with modern pharmaceutical manufacturing technologies.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on TIANYANG Pharmaceutical.